Skip to main content

Sequencing service

The service analyses the resistance that HIV can present to antiretroviral treatment.

Imatge de Servei Sequenciacio

Study of the HIV genome for a more effective treatment

The sequencing service sequences reverse transcriptase, protease and/or integrase genes to detect mutations that imply genotypic HIV resistance to antiretroviral drugs. It also performs the HIV genotypic tropism test, which determines the cellular receptor used by HIV to enter cells, with resistance determined from plasma. For low virus loads in blood, samples are ultracentrifuged to obtain evaluable results from patient plasma.  

The Sequencing Service, launched in 1999, has been a designated reference centre for antiretroviral resistance testing by the Catalan Health Service (CatSalut) since 2002. It also participates in research projects and clinical trials with other institutions and pharmaceutical companies. 

This service is part of the CERCA GINYS platform, funded by CERCA with the support of the Spanish Ministry of Science and Innovation.


More information 

Head: Teresa Puig

Not available in
This is not available in . You can go to the translated versions in these languages: